PL315513A1 - Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells - Google Patents

Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells

Info

Publication number
PL315513A1
PL315513A1 PL94315513A PL31551394A PL315513A1 PL 315513 A1 PL315513 A1 PL 315513A1 PL 94315513 A PL94315513 A PL 94315513A PL 31551394 A PL31551394 A PL 31551394A PL 315513 A1 PL315513 A1 PL 315513A1
Authority
PL
Poland
Prior art keywords
cytolytical
application
blood cells
peripheral blood
activity stimulation
Prior art date
Application number
PL94315513A
Other versions
PL175343B1 (en
Inventor
Martin A Schwarz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL315513A1 publication Critical patent/PL315513A1/en
Publication of PL175343B1 publication Critical patent/PL175343B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PL94315513A 1994-01-20 1994-01-20 Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells PL175343B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN94194863A CN1142186A (en) 1994-01-20 1994-01-20 Cytolytic activity of peripheral blood mononuclear cells activated by interleukin-10
PCT/IB1994/000008 WO1995019780A1 (en) 1994-01-20 1994-01-20 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity

Publications (2)

Publication Number Publication Date
PL315513A1 true PL315513A1 (en) 1996-11-12
PL175343B1 PL175343B1 (en) 1998-12-31

Family

ID=37708148

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94315513A PL175343B1 (en) 1994-01-20 1994-01-20 Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells

Country Status (10)

Country Link
EP (1) EP0740552A1 (en)
JP (1) JPH09508116A (en)
CN (1) CN1142186A (en)
AU (1) AU707019B2 (en)
FI (1) FI962813L (en)
NO (1) NO963029L (en)
NZ (1) NZ259584A (en)
PL (1) PL175343B1 (en)
SK (1) SK91696A3 (en)
WO (1) WO1995019780A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685931B1 (en) 1998-12-22 2004-02-03 Schering Corporation Treatment of hepatitis C virus infections with interleukin-10
ATE516820T1 (en) 2000-09-29 2011-08-15 Schering Corp PEGYLATED INTERLEUKIN 10
RU2322452C2 (en) * 2006-03-27 2008-04-20 Михаил Николаевич Смирнов Immunomodulating composition
NZ597098A (en) 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
EP2170394A4 (en) * 2007-06-27 2011-09-28 Joslin Diabetes Center Inc REGULATORY T CELLS IN ADIPOSIVE TISSUE
EP3348281B1 (en) 2008-12-17 2023-07-05 Merck Sharp & Dohme Corp. Mono- and di-peg il-10 production; and uses
CN105209054A (en) 2013-04-18 2015-12-30 阿尔莫生物科技股份有限公司 Methods of treating diseases and conditions using interleukin-10
JP2016528879A (en) 2013-06-17 2016-09-23 アルモ・バイオサイエンシーズ・インコーポレイテッド Methods for assessing protein identity and stability
HK1226308A1 (en) 2013-08-30 2017-09-29 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US11413332B2 (en) 2013-11-11 2022-08-16 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
KR20170068553A (en) 2014-10-14 2017-06-19 아르모 바이오사이언시스 인코포레이티드 Interleukin-15 compositions and uses thereof
JP6675394B2 (en) 2014-10-22 2020-04-01 アルモ・バイオサイエンシーズ・インコーポレイテッド Use of interleukin-10 for the treatment of diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
JP7053453B2 (en) 2015-08-25 2022-04-12 アルモ・バイオサイエンシーズ・インコーポレイテッド How to use interleukin 10 to treat diseases and disorders
EP4422668A1 (en) * 2021-10-25 2024-09-04 Ellennbe GmbH Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068705T3 (en) * 1991-01-16 1995-04-16 Schering Corp TREATMENT OF NEOPLASTIC DISEASE WITH INTERLEUKIN-10.
WO1992012726A1 (en) * 1991-01-16 1992-08-06 Schering Corporation Use of interleukin-10 in adoptive immunotherapy of cancer
US5055045A (en) * 1991-03-18 1991-10-08 Dickie Robert G Disposable dental matrix retainer clamp

Also Published As

Publication number Publication date
FI962813A7 (en) 1996-07-11
AU5842594A (en) 1995-08-08
AU707019B2 (en) 1999-07-01
NO963029D0 (en) 1996-07-19
PL175343B1 (en) 1998-12-31
CN1142186A (en) 1997-02-05
JPH09508116A (en) 1997-08-19
FI962813A0 (en) 1996-07-11
NZ259584A (en) 1998-01-26
NO963029L (en) 1996-09-19
EP0740552A1 (en) 1996-11-06
WO1995019780A1 (en) 1995-07-27
SK91696A3 (en) 1997-04-09
FI962813L (en) 1996-07-11

Similar Documents

Publication Publication Date Title
GB8524455D0 (en) Monitoring activity of peripheral devices
EP0161770A3 (en) Lysing agent for analysis of peripheral blood cells
ZW18986A1 (en) Collection of human body discharge
HU9502918D0 (en) Pharmaceutical composition of antihypertriglyceridemic activity
FI962813L (en) Use of IL-10 to stimulate cytolytic activity of peripheral blood mononuclear cells
PH22293A (en) Thienopyridone compounds and compositions with therapeutic activity
FI953186A7 (en) Assessment of bone cell activity
PL327732A1 (en) Compounds of therapeutic activity
PL336760A1 (en) Treatment of skin diseases
ZA867839B (en) Biologically active derivatives of human ypsilon-interferon
IL108318A0 (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
GB2189144B (en) Zinc complex of 5-chloro-7-iodo-8hydroxyquinoline having antimycotic activity and therapeutic use thereof.
AU8398398A (en) Modification of nitric oxide activity to treat fas-induced pathologies
HU9601989D0 (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
GB9721075D0 (en) Materials and methods relating to the stimulation of cells
GB8729549D0 (en) Electrode for skin treatment
PL311885A1 (en) Protein of tpo activity
AU2604895A (en) Short-term anti-cd3 stimulation of lymphocytes to increase their (in vivo) activity
AU8999298A (en) Protein having activity of activiting nerve cell functions
EP0576862A3 (en) Dna for immortalisation of human or animal cells
GB2275780B (en) Methods of measuring and controlling activity of zinc phosphate treatment solution
CS116086A1 (en) Agent with biological and bactericidal activity
AU586029B2 (en) Collection of human body discharge
HUT74175A (en) Lysozime-containing combined products of antimicrobial activity for human therapy
GB9715372D0 (en) Skin treatment pack and process